Cross-tumoral Phase 2 With Crizotinib in Europe

[Olga]

If you are in Europe and have no any other options for treatment of the metastatic ASPS, you may consider enrolling into this trial:

Cross-tumoral Phase 2 With Crizotinib
http://clinicaltrials.gov/ct2/show/NCT01524926

Official Title: Cross-tumoral Phase 2 Clinical Trial Exploring Crizotinib (PF-02341066) in Patients With Advanced Tumors Induced by Causal Alterations of ALK and/or MET ("CREATE")
The study will primarily assess the antitumor activity of crizotinib in a variety of tumors with alterations in ALK and/or MET pathways including ASPS.
Ages Eligible for Study: 15 Years and older
Locations
Belgium
Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Recruiting
Brussels, Belgium
U.Z. Gasthuisberg Recruiting
Leuven, Belgium

[Jorge]

Does anyone in our community ever take Crizotinib? Can you share us how it works on ASPS?

Thank you.